MELANIE ANDERSON: Open Payments
NPI 1013075423 · THORNTON, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,262 in 115 payments from 27 companies in 2025. Trend: 2023 $2,921 · 2024 $2,693 · 2025 $2,262
Food & beverage: $2,262
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 17 | $487 |
| ABBVIE INC. | 32 | $438 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 11 | $161 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $125 |
| Novo Nordisk Inc | 6 | $110 |
| Lilly USA, LLC | 5 | $98 |
| PFIZER INC. | 4 | $80 |
| Amgen Inc. | 4 | $72 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $69 |
| SANOFI-AVENTIS U.S. LLC | 2 | $68 |
Products named: VRAYLAR, JARDIANCE, AIRSUPRA, CAPLYTA, FARXIGA, Wegovy, QULIPTA, Kerendia.
Industry payments across CO — which companies pay providers there.
